TotalMarketCap

Senti Biosciences

SNTINasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$6.330 M

$0.16 -6.79%

Close of 6 Nov 2026

As of 6 Nov 2026, Senti Biosciences (SNTI) has a market capitalization of $6.33M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$61.4M

Loss-making

Shares outstanding

31,144,754

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #150Intensity TherapeuticsINTS$10.2M
  2. #151In8bioINAB$8.30M
  3. #152Senti BiosciencesSNTI$6.33M
  4. #153AIM ImmunoTechAIM$6.14M
  5. #154CurisCRIS$5.84M

What if Senti Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$734,289.35

Per share 4,461,053× higher

Bitcoin $1.53T

$39,731.12

Per share 241,380× higher

Apple $5.02T

$130,433.55

Per share 792,427× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Senti Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.